Skip to main content
Top
Published in: Current Pain and Headache Reports 5/2016

01-05-2016 | Other Pain (N Vadivelu and A Kaye, Section Editors)

Pain Control in the Presence of Drug Addiction

Authors: Nalini Vadivelu, Leandro Lumermann, Richard Zhu, Gopal Kodumudi, Amir O. Elhassan, Alan David Kaye

Published in: Current Pain and Headache Reports | Issue 5/2016

Login to get access

Abstract

Drug addiction is present in a significant proportion of the population in the USA and worldwide. Drug addiction can occur with the abuse of many types of substances including cocaine, marijuana, stimulants, alcohol, opioids, and tranquilizers. There is a high likelihood that clinicians will encounter patients with substance abuse disorders on a regular basis with the prevalence of the use of illicit substances and the high rate of abuse of prescription drugs. The use of abuse deterrent formulations of prescription opioid agents, pill counts, and urine drug abuse screenings are all useful strategies. Optimum pain management of patients with addiction in the outpatient and inpatient setting is essential to minimize pain states. Careful selection of medications and appropriate oversight, including drug agreements, can reduce drug-induced impairments, including sleep deficits and diminished physical, social, and sexual functioning. This review, therefore, discusses the prevalence of illicit and prescription drug addiction, the challenges of achieving optimum pain control, and the therapeutic approaches to be considered in this challenging population. More research is warranted to develop improved therapies and routes of treatments for optimum pain relief and to prevent the development of central sensitization, chronic pain, and impaired physical and social functioning in patients with drug addiction.
Literature
1.
go back to reference Manchikanti L, Pampati V, Damron KS, Fellows B, Barnhill RC, Beyer CD. Prevalence of opioid abuse in interventional pain medicine practice settings: a randomized clinical evaluation. Pain Physician. 2001;4(4):358–65.PubMed Manchikanti L, Pampati V, Damron KS, Fellows B, Barnhill RC, Beyer CD. Prevalence of opioid abuse in interventional pain medicine practice settings: a randomized clinical evaluation. Pain Physician. 2001;4(4):358–65.PubMed
2.
go back to reference Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician. 2003;6(2):173–8.PubMed Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician. 2003;6(2):173–8.PubMed
3.
go back to reference Public policy statement on definitions related to the use of opioids in pain treatment. American Society of Addiction Medicine. Journal of addictive diseases. 1998;17(2):129–33. Public policy statement on definitions related to the use of opioids in pain treatment. American Society of Addiction Medicine. Journal of addictive diseases. 1998;17(2):129–33.
4.
go back to reference American Academy of Pain Medicine tAPS, the American Society of Addiction M. Definitions related to the use of opioids for the treatment of pain. WMJ. 2001;100(5):28–9. American Academy of Pain Medicine tAPS, the American Society of Addiction M. Definitions related to the use of opioids for the treatment of pain. WMJ. 2001;100(5):28–9.
5.
go back to reference Bădilă E, Hostiuc M, Weiss E, Bartoş D. Illicit drugs and their impact on cardiovascular pathology. Rom J Intern Med. 2015;53(3):218–25.PubMed Bădilă E, Hostiuc M, Weiss E, Bartoş D. Illicit drugs and their impact on cardiovascular pathology. Rom J Intern Med. 2015;53(3):218–25.PubMed
6.
go back to reference Whitby LG, Hertting G, Axelrod J. Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature. 1960;187:604–5.CrossRefPubMed Whitby LG, Hertting G, Axelrod J. Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature. 1960;187:604–5.CrossRefPubMed
7.
go back to reference Foltin RW, Ward AS, Haney M, Hart CL, Collins ED. The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend. 2003;70(2):149–57.CrossRefPubMed Foltin RW, Ward AS, Haney M, Hart CL, Collins ED. The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend. 2003;70(2):149–57.CrossRefPubMed
8.
go back to reference Pavarin R, Lugoboni F, Mathewson S, Ferrari AM, Guizzardi G, Quaglio G. Cocaine-related medical and trauma problems: a consecutive series of 743 patients from a multicentre study in Italy. European journal of emergency medicine : official journal of the European Society for Emergency Medicine. 2011;18(4):208–14.CrossRef Pavarin R, Lugoboni F, Mathewson S, Ferrari AM, Guizzardi G, Quaglio G. Cocaine-related medical and trauma problems: a consecutive series of 743 patients from a multicentre study in Italy. European journal of emergency medicine : official journal of the European Society for Emergency Medicine. 2011;18(4):208–14.CrossRef
9.
go back to reference Irwin MR, Bjurstrom MF, Olmstead R. Polysomnographic measures of sleep in cocaine dependence and alcohol dependence: implications for age-related loss of slow wave, stage 3 sleep. Addiction. 2016 Irwin MR, Bjurstrom MF, Olmstead R. Polysomnographic measures of sleep in cocaine dependence and alcohol dependence: implications for age-related loss of slow wave, stage 3 sleep. Addiction. 2016
10.
go back to reference Tang Y, Martin NL, Cotes RO. Cocaine-induced psychotic disorders: presentation, mechanism, and management. J Dual Diagn. 2014;10(2):98–105.CrossRefPubMed Tang Y, Martin NL, Cotes RO. Cocaine-induced psychotic disorders: presentation, mechanism, and management. J Dual Diagn. 2014;10(2):98–105.CrossRefPubMed
11.
12.
go back to reference Seyit M, Erdur B, Kortunay S, Yuksel A, Yilmaz A, Ozen M, et al. A comparison of dexmedetomidine, moxonidine and alpha-methyldopa effects on acute, lethal cocaine toxicity. Iran Red Crescent Med J. 2015;17(6):e18780.PubMedPubMedCentral Seyit M, Erdur B, Kortunay S, Yuksel A, Yilmaz A, Ozen M, et al. A comparison of dexmedetomidine, moxonidine and alpha-methyldopa effects on acute, lethal cocaine toxicity. Iran Red Crescent Med J. 2015;17(6):e18780.PubMedPubMedCentral
13.
go back to reference Conroy DA, Kurth ME, Strong DR, Brower KJ, Stein MD. Marijuana use patterns and sleep among community-based young adults. J Addict Dis. 2016:0 Conroy DA, Kurth ME, Strong DR, Brower KJ, Stein MD. Marijuana use patterns and sleep among community-based young adults. J Addict Dis. 2016:0
15.
go back to reference Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536.CrossRefPubMedPubMedCentral Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536.CrossRefPubMedPubMedCentral
16.•
go back to reference Moran S, Isa J, Steinemann S. Perioperative management in the patient with substance abuse. Surg Clin North Am. 2015;95(2):417–28. Recently published article regarding perioperative management of pain in patients with substance abuse disorder. The article covers an extensive list of drugs of abuse and the management strategies of choice.CrossRefPubMed Moran S, Isa J, Steinemann S. Perioperative management in the patient with substance abuse. Surg Clin North Am. 2015;95(2):417–28. Recently published article regarding perioperative management of pain in patients with substance abuse disorder. The article covers an extensive list of drugs of abuse and the management strategies of choice.CrossRefPubMed
17.
go back to reference Dowling K, Storr CL, Chilcoat HD. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. The Clinical journal of pain. 2006;22(9):776–83.CrossRefPubMed Dowling K, Storr CL, Chilcoat HD. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. The Clinical journal of pain. 2006;22(9):776–83.CrossRefPubMed
18.
go back to reference Bingham CR, Shope JT, Tang X. Drinking behavior from high school to young adulthood: differences by college education. Alcohol Clin Exp Res. 2005;29(12):2170–80.CrossRefPubMedPubMedCentral Bingham CR, Shope JT, Tang X. Drinking behavior from high school to young adulthood: differences by college education. Alcohol Clin Exp Res. 2005;29(12):2170–80.CrossRefPubMedPubMedCentral
20.
go back to reference Rezaei F, Ghaderi E, Mardani R, Hamidi S, Hassanzadeh K. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial. Fundam Clin Pharmacol. 2016. Rezaei F, Ghaderi E, Mardani R, Hamidi S, Hassanzadeh K. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial. Fundam Clin Pharmacol. 2016.
21.
go back to reference Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789–90.CrossRefPubMed Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789–90.CrossRefPubMed
22.
go back to reference Vadivelu N, Mitra S, Kaye AD, Urman RD. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best practice & research Clinical anaesthesiology. 2014;28(1):91–101.CrossRef Vadivelu N, Mitra S, Kaye AD, Urman RD. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best practice & research Clinical anaesthesiology. 2014;28(1):91–101.CrossRef
23.
go back to reference Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H-50)2015 September 13, 2015. Available from: http://www.samhsa.gov/data/ Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H-50)2015 September 13, 2015. Available from: http://​www.​samhsa.​gov/​data/​
24.
go back to reference Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2002–2012. State admissions to substance abuse treatment services. BHSIS Series S-72, HHS Publication No. (SMA) 14–4889. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014. [Internet]. [cited October 8, 2015]. Available from: http://www.samhsa.gov/data. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2002–2012. State admissions to substance abuse treatment services. BHSIS Series S-72, HHS Publication No. (SMA) 14–4889. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014. [Internet]. [cited October 8, 2015]. Available from: http://​www.​samhsa.​gov/​data.
25.
go back to reference Rosenblatt AB, Mekhail NA. Management of pain in addicted/illicit and legal substance abusing patients. Pain practice : the official journal of World Institute of Pain. 2005;5(1):2–10.CrossRef Rosenblatt AB, Mekhail NA. Management of pain in addicted/illicit and legal substance abusing patients. Pain practice : the official journal of World Institute of Pain. 2005;5(1):2–10.CrossRef
26.
go back to reference Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. The Clinical journal of pain. 2002;18(4 Suppl):S61–9.CrossRefPubMed Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. The Clinical journal of pain. 2002;18(4 Suppl):S61–9.CrossRefPubMed
27.
go back to reference Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94(3):135–40.PubMed Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94(3):135–40.PubMed
28.
go back to reference Buchsbaum DG, Buchanan RG, Centor RM, Schnoll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 1991;115(10):774–7.CrossRefPubMed Buchsbaum DG, Buchanan RG, Centor RM, Schnoll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 1991;115(10):774–7.CrossRefPubMed
29.
go back to reference Peppin JF, Passik SD, Couto JE, Fine PG, Christo PJ, Argoff C, et al. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med. 2012;13(7):886–96.CrossRefPubMed Peppin JF, Passik SD, Couto JE, Fine PG, Christo PJ, Argoff C, et al. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med. 2012;13(7):886–96.CrossRefPubMed
30.
31.
go back to reference Gordon S, Toepper WC, Blackman SC. Toxicology screening in adolescent trauma. Pediatr Emerg Care. 1996;12(1):36–9.CrossRefPubMed Gordon S, Toepper WC, Blackman SC. Toxicology screening in adolescent trauma. Pediatr Emerg Care. 1996;12(1):36–9.CrossRefPubMed
32.
go back to reference Erickson T, Orsay E. Toxicology screening and substance abuse consultations in acutely traumatized patients. The American journal of emergency medicine. 1994;12(1):126–7.CrossRefPubMed Erickson T, Orsay E. Toxicology screening and substance abuse consultations in acutely traumatized patients. The American journal of emergency medicine. 1994;12(1):126–7.CrossRefPubMed
33.
go back to reference Sinatra R. Causes and consequences of inadequate management of acute pain. Pain medicine. 2010;11(12):1859–71.CrossRefPubMed Sinatra R. Causes and consequences of inadequate management of acute pain. Pain medicine. 2010;11(12):1859–71.CrossRefPubMed
34.
go back to reference Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain physician. 2011;14(2):145–61.PubMed Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain physician. 2011;14(2):145–61.PubMed
35.
go back to reference Mehta V, Langford RM. Acute pain management for opioid dependent patients. Anaesthesia. 2006;61(3):269–76.CrossRefPubMed Mehta V, Langford RM. Acute pain management for opioid dependent patients. Anaesthesia. 2006;61(3):269–76.CrossRefPubMed
36.
go back to reference Doverty M, Somogyi AA, White JM, Bochner F, Beare CH, Menelaou A, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 2001;93(2):155–63.CrossRefPubMed Doverty M, Somogyi AA, White JM, Bochner F, Beare CH, Menelaou A, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 2001;93(2):155–63.CrossRefPubMed
37.
go back to reference Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. Journal of opioid management. 2006;2(5):277–82.PubMed Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. Journal of opioid management. 2006;2(5):277–82.PubMed
38.
go back to reference McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. The journal of pain : official journal of the American Pain Society. 2003;4(5):231–56.CrossRef McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. The journal of pain : official journal of the American Pain Society. 2003;4(5):231–56.CrossRef
39.
go back to reference Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.CrossRefPubMedPubMedCentral Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.CrossRefPubMedPubMedCentral
40.
go back to reference Prater CD, Zylstra RG, Miller KE. Successful pain management for the recovering addicted patient. Primary care companion to the Journal of clinical psychiatry. 2002;4(4):125–31.CrossRefPubMedPubMedCentral Prater CD, Zylstra RG, Miller KE. Successful pain management for the recovering addicted patient. Primary care companion to the Journal of clinical psychiatry. 2002;4(4):125–31.CrossRefPubMedPubMedCentral
41.
go back to reference Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnsten JH. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manag. 2004;28(5):517–25.CrossRef Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnsten JH. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manag. 2004;28(5):517–25.CrossRef
42.
43.
go back to reference Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag. 2014;10(6):375–82.CrossRefPubMed Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag. 2014;10(6):375–82.CrossRefPubMed
44.
go back to reference Heit HA. The truth about pain management: the difference between a pain patient and an addicted patient. Eur J Pain. 2001;5(Suppl A):27–9.CrossRefPubMed Heit HA. The truth about pain management: the difference between a pain patient and an addicted patient. Eur J Pain. 2001;5(Suppl A):27–9.CrossRefPubMed
45.
go back to reference Gourlay DL, Heit HA. Pain and addiction: managing risk through comprehensive care. J Addict Dis. 2008;27(3):23–30.CrossRefPubMed Gourlay DL, Heit HA. Pain and addiction: managing risk through comprehensive care. J Addict Dis. 2008;27(3):23–30.CrossRefPubMed
46.••
go back to reference Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–12. Well articulated article which describes the challenges and important points to consider when prescribing opioids to individuals at risk for addiction.CrossRefPubMed Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–12. Well articulated article which describes the challenges and important points to consider when prescribing opioids to individuals at risk for addiction.CrossRefPubMed
47.
go back to reference Laroche F, Rostaing S, Aubrun F, Perrot S. Pain management in heroin and cocaine users. Joint Bone Spine. 2012;79(5):446–50.CrossRefPubMed Laroche F, Rostaing S, Aubrun F, Perrot S. Pain management in heroin and cocaine users. Joint Bone Spine. 2012;79(5):446–50.CrossRefPubMed
48.
go back to reference Miotto K, Kaufman A, Kong A, Jun G, Schwartz J. Managing co-occurring substance use and pain disorders. Psychiatr Clin North Am. 2012;35(2):393–409.CrossRefPubMed Miotto K, Kaufman A, Kong A, Jun G, Schwartz J. Managing co-occurring substance use and pain disorders. Psychiatr Clin North Am. 2012;35(2):393–409.CrossRefPubMed
49.
go back to reference Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manag. 1999;18(1):27–37.CrossRef Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manag. 1999;18(1):27–37.CrossRef
50.
51.
go back to reference Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain physician. 2006;9(3):215–25. Prospective study with relatively significant sample size investigating the prevalence of illicit drug use and controlled substance abuse in patients receiving chronic pain management.PubMed Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain physician. 2006;9(3):215–25. Prospective study with relatively significant sample size investigating the prevalence of illicit drug use and controlled substance abuse in patients receiving chronic pain management.PubMed
Metadata
Title
Pain Control in the Presence of Drug Addiction
Authors
Nalini Vadivelu
Leandro Lumermann
Richard Zhu
Gopal Kodumudi
Amir O. Elhassan
Alan David Kaye
Publication date
01-05-2016
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 5/2016
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-016-0561-0

Other articles of this Issue 5/2016

Current Pain and Headache Reports 5/2016 Go to the issue

Childhood and Adolescent Headache (S Evers, Section Editor)

The Link Between Infantile Colic and Migraine

Other Pain (N Vadivelu and A Kaye, Section Editors)

Role of Alternative Therapies for Chronic Pain Syndromes

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

No Laughing Matter: Gelastic Migraine and Other Unusual Headache Syndromes

Other Pain (N Vadivelu and A Kaye, Section Editors)

Current State of Opioid Therapy and Abuse

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Ice Pick Headache

Other Pain (N Vadivelu and A Kaye, Section Editors)

New Chronic Pain Treatments in the Outpatient Setting: Review Article